Artificial Pancreas Systems Market size in terms of volume and value 2016-2026
The Diabetes Type 1 segment was estimated to account for a little more than 95% market share in terms of value in the North America and Europe artificial pancreas systems market by 2016 end and is expected to experience an increase of more than 200 BPS in its market share by 2026 over 2016. The Diabetes Type 1 segment is expected to register high Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment is projected to increase at a CAGR of 12.9% over the forecast period to reach more than US$ 250 Mn by 2026. On the other hand the Diabetes Type 2 segment is expected to register low Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment to the North America and Europe artificial pancreas systems market is expected to increase at a CAGR of 4.1% over the forecast period. The Diabetes Type 1 segment dominated the North America and Europe artificial pancreas systems market in revenue terms in 2015, and the trend is projected to continue throughout the forecast period. The Diabetes Type 2 segment is expected to remain the least attractive segment in the North America and Europe artificial pancreas systems market in revenue terms with a low market attractiveness index of 0.02 over the forecast period. Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-na-3058
The Diabetes Type 1 segment was estimated to account for a little more than 95% market share in terms of value in the North America and Europe artificial pancreas systems market by 2016 end and is expected to experience an increase of more than 200 BPS in its market share by 2026 over 2016. The Diabetes Type 1 segment is expected to register high Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment is projected to increase at a CAGR of 12.9% over the forecast period to reach more than US$ 250 Mn by 2026. On the other hand the Diabetes Type 2 segment is expected to register low Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment to the North America and Europe artificial pancreas systems market is expected to increase at a CAGR of 4.1% over the forecast period. The Diabetes Type 1 segment dominated the North America and Europe artificial pancreas systems market in revenue terms in 2015, and the trend is projected to continue throughout the forecast period. The Diabetes Type 2 segment is expected to remain the least attractive segment in the North America and Europe artificial pancreas systems market in revenue terms with a low market attractiveness index of 0.02 over the forecast period.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-na-3058
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Artificial</strong> <strong>Pancreas</strong> <strong>Systems</strong> <strong>Market</strong>: North America <strong>and</strong><br />
Europe Industry Analysis <strong>and</strong> Opportunity Assessment,<br />
<strong>2016</strong>–<strong>2026</strong><br />
April 2017<br />
Report Id : REP-NA-3058<br />
Status : Apr -2017<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider <strong>of</strong> syndicated research reports, custom<br />
research reports, <strong>and</strong> consult<strong>in</strong>g services. We deliver a complete packaged solution, which<br />
comb<strong>in</strong>es current market <strong>in</strong>telligence, statistical anecdotes, technology <strong>in</strong>puts, valuable growth<br />
<strong>in</strong>sights, aerial view <strong>of</strong> the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions <strong>in</strong>clude GCC,<br />
ASEAN, <strong>and</strong> BRIC.<br />
Our <strong>of</strong>fer<strong>in</strong>gs cover a broad spectrum <strong>of</strong> <strong>in</strong>dustries <strong>in</strong>clud<strong>in</strong>g Chemicals, Materials, Energy,<br />
Technology, Healthcare, <strong>and</strong> Retail.<br />
We have a global presence with delivery centers across India specializ<strong>in</strong>g <strong>in</strong> provid<strong>in</strong>g global<br />
research reports <strong>and</strong> country research reports. FMI is headquartered out <strong>of</strong> London, U.K., with a<br />
state-<strong>of</strong>-the-art delivery center located <strong>in</strong> Pune, India. We comb<strong>in</strong>e our knowledge <strong>and</strong> learn<strong>in</strong>g<br />
from every corner <strong>of</strong> the world to distill it to one th<strong>in</strong>g – the perfect solution for our client.<br />
Research Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized Research<br />
Syndicated Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Automotive <strong>and</strong> Transportation<br />
Electronics, Semiconductor, <strong>and</strong> ICT<br />
Retail <strong>and</strong> Consumer Products<br />
Industrial Automation <strong>and</strong> Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food <strong>and</strong> Beverages<br />
Services <strong>and</strong> Utilities<br />
Energy, M<strong>in</strong><strong>in</strong>g, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription <strong>in</strong>formation please contact<br />
Hari. T (Sr. Manager - Global Bus<strong>in</strong>ess Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarket<strong>in</strong>sights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
Systematic Research Approach<br />
<strong>Market</strong> pr<strong>of</strong>il<strong>in</strong>g<br />
Formulat<strong>in</strong>g discussion guide<br />
Develop<strong>in</strong>g list <strong>of</strong> respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascerta<strong>in</strong> overall market <strong>size</strong>, top<br />
<strong>in</strong>dustry players, top products, <strong>in</strong>dustry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide to conduct expert <strong>and</strong> <strong>in</strong>dustry<br />
<strong>in</strong>terviews<br />
PMR develops a list <strong>of</strong> <strong>in</strong>dustry players<br />
(manufacturers), distributors, retailers<br />
<strong>and</strong> <strong>in</strong>dustry experts<br />
PMR conducts <strong>in</strong>terviews with <strong>in</strong>dustry<br />
experts, <strong>in</strong>dustry players, distributors<br />
<strong>and</strong> retailers<br />
Data is validated by triangulation<br />
method, where<strong>in</strong> secondary, primary<br />
<strong>and</strong> PMR analysis contribute to the f<strong>in</strong>al<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& Analysis<br />
Identify<strong>in</strong>g key op<strong>in</strong>ion leaders<br />
Questionnaire design<br />
In-depth <strong>in</strong>terviews<br />
Coverage across <strong>value</strong> cha<strong>in</strong><br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapp<strong>in</strong>g as per <strong>value</strong> cha<strong>in</strong><br />
Key focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
Analysis<br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Bus<strong>in</strong>ess<br />
Solution<br />
Key <strong>in</strong>dustry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrut<strong>in</strong>ized us<strong>in</strong>g MS-Excel to<br />
obta<strong>in</strong> qualitative <strong>and</strong> quantitative<br />
<strong>in</strong>sights about the <strong>in</strong>dustry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers <strong>in</strong>dustry <strong>in</strong>sights <strong>and</strong><br />
<strong>in</strong>formation <strong>in</strong> the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
L<strong>in</strong>ked<strong>in</strong><br />
Zoom<strong>in</strong>fo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
F<strong>in</strong>ancial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# <strong>in</strong>cludes sources <strong>of</strong> databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
North America <strong>and</strong> Europe <strong>Artificial</strong> <strong>Pancreas</strong> <strong>Systems</strong> <strong>Market</strong><br />
Ris<strong>in</strong>g Type 1 Diabetics <strong>in</strong> North America & Europe Trigger<strong>in</strong>g the Need for <strong>Artificial</strong> <strong>Pancreas</strong> <strong>Systems</strong><br />
Grow<strong>in</strong>g number <strong>of</strong> diabetics <strong>in</strong> the US, Canada <strong>and</strong> European countries has been compell<strong>in</strong>g hospitals to<br />
keep artificial pancreas systems <strong>in</strong> stock. Government-funded organisations <strong>in</strong> North America <strong>and</strong> Europe<br />
are collaborat<strong>in</strong>g with local as well as global medical device manufacturers to meet the ris<strong>in</strong>g dem<strong>and</strong> for<br />
artificial pancreas systems. A latest report published by Future <strong>Market</strong> Insights reveals that the <strong>value</strong> <strong>of</strong><br />
artificial pancreas systems market <strong>in</strong> North America <strong>and</strong> Europe reached US$ 86.5 Mn by the end <strong>of</strong><br />
<strong>2016</strong>. The report also predicts that people suffer<strong>in</strong>g from diabetes <strong>in</strong> these regions will keep opt<strong>in</strong>g for<br />
artificial pancreas systems <strong>in</strong> order to control their blood sugar levels externally.<br />
Lifestyle <strong>of</strong> residents <strong>in</strong> Europe <strong>and</strong> North America is trigger<strong>in</strong>g the <strong>in</strong>cidence <strong>of</strong> diabetes (type 1 as well<br />
as type 2) <strong>in</strong> these regions. Substantial rise <strong>in</strong> diabetic patients compels doctors, pathologists <strong>and</strong><br />
endocr<strong>in</strong>ologists to treat patients’ malfunction<strong>in</strong>g pancreas superficially. The rate at which a physiological<br />
pancreas get replaced with a substitute (artificial pancreas system) will keep ga<strong>in</strong><strong>in</strong>g momentum <strong>in</strong> this<br />
region. By the end <strong>of</strong> <strong>2026</strong>, more than US$ 280 Mn worth <strong>of</strong> artificial pancreas systems will be sold <strong>in</strong><br />
North America <strong>and</strong> Europe, register<strong>in</strong>g a revenue growth at 12.6% CAGR.<br />
Almost every artificial pancreas system sold <strong>in</strong> these regions will treat patients suffer<strong>in</strong>g from type 1<br />
diabetes. In US, the occurrence <strong>of</strong> diabetes mellitus type 1 is expected to surge beyond control. The US<br />
artificial pancreas systems market is presently <strong>value</strong>d at just over US$ 40 Mn, <strong>and</strong> will account for over<br />
two-third <strong>of</strong> North America’s artificial pancreas system revenues through <strong>2026</strong>. Canada’s artificial<br />
pancreas system revenues, on the other h<strong>and</strong>, will surge rampantly at 13.8% CAGR.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
North America <strong>and</strong> Europe <strong>Artificial</strong> <strong>Pancreas</strong> <strong>Systems</strong> <strong>Market</strong><br />
Hospitals will rema<strong>in</strong> the largest distribution channel for artificial pancreas systems across North America<br />
<strong>and</strong> Europe. Although, the report does highlight a noticeable presence <strong>of</strong> e-commerce websites <strong>in</strong> global<br />
distribution <strong>of</strong> medical devices as critical as artificial pancreas systems. Among these regions, North<br />
America will rema<strong>in</strong> dom<strong>in</strong>ant over Europe’s artificial pancreas system market. Likewise, the dem<strong>and</strong> for<br />
artificial pancreas systems will be fairly high <strong>in</strong> Western Europe, compared to Eastern Europe. Germany,<br />
France, the UK <strong>and</strong> Pol<strong>and</strong> are lead<strong>in</strong>g European countries that are more likely to showcase revenue<br />
growth at over 11.5% CAGR.<br />
One <strong>of</strong> the largest company <strong>in</strong> North America & Europe’s artificial pancreas systems market has been<br />
identified as Ill<strong>in</strong>ois-based medical device manufacturer – Medtronic plc. With it, the UK-based Cellnovo<br />
is also be<strong>in</strong>g recognised as a prom<strong>in</strong>ent manufacturer <strong>of</strong> artificial pancreas systems. Other key players <strong>in</strong><br />
the artificial pancreas systems market across North America <strong>and</strong> Europe <strong>in</strong>clude, Johnson & Johnson<br />
Services, Inc., Dexcom Inc., Insulet Corporation, <strong>and</strong> T<strong>and</strong>em Diabetes Care Inc.<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
Table <strong>of</strong> Content<br />
1. Executive Summary<br />
2. <strong>Market</strong> Introduction<br />
2.1. <strong>Market</strong> Def<strong>in</strong>ition<br />
2.2. <strong>Market</strong> Taxonomy<br />
3. North America <strong>and</strong> Europe <strong>Artificial</strong> <strong>Pancreas</strong> Device System <strong>Market</strong> Analysis Scenario<br />
3.1. <strong>Market</strong> Size (US$ Mn) <strong>and</strong> Forecast<br />
3.1.1. <strong>Market</strong> Size <strong>and</strong> Y-o-Y Growth<br />
3.1.2. Absolute $ Opportunity<br />
3.3. <strong>Market</strong> Overview<br />
4. <strong>Market</strong> Dynamics<br />
4.1. Macro-economic Factors<br />
4.2. Drivers<br />
4.2.1. Supply Side<br />
4.2.2. Dem<strong>and</strong> Side<br />
4.3. Restra<strong>in</strong>ts<br />
4.4. Opportunity<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
6
Table <strong>of</strong> Content<br />
5. North America <strong>and</strong> Europe <strong>Artificial</strong> <strong>Pancreas</strong> Device System <strong>Market</strong> Analysis <strong>and</strong> Fore casts, By<br />
Disease Indication<br />
5.1. Introduction<br />
5.2. Basis Po<strong>in</strong>t Share (BPS) Analysis By Disease Indication<br />
5.3. Y-o-Y Growth Projections By Disease Indication<br />
5.4. <strong>Market</strong> Value Forecast By Disease Indication, <strong>2016</strong>–<strong>2026</strong><br />
5.4.1. Diabetes Type 1<br />
5.4.2. Diabetes Type 2<br />
5.5. Prom<strong>in</strong>ent Trends<br />
5.6. <strong>Market</strong> Attractiveness By Disease Indication<br />
6. North America <strong>and</strong> Europe <strong>Artificial</strong> <strong>Pancreas</strong> Device System <strong>Market</strong> Analysis <strong>and</strong> Forecast, By<br />
Distribution Channel<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
7
Table <strong>of</strong> Content<br />
6.1. Introduction<br />
6.2. Basis Po<strong>in</strong>t Share (BPS) Analysis By Distribution Channel<br />
6.3. Y-o-Y Growth Projections By Distribution Channel<br />
6.4. <strong>Market</strong> Value Forecast By Distribution Channel, <strong>2016</strong>–<strong>2026</strong><br />
6.4.1. Hospitals<br />
6.4.2. E-Commerce<br />
6.5. Drivers <strong>and</strong> Restra<strong>in</strong>ts: Impact Analysis<br />
6.6. <strong>Market</strong> Attractiveness By Distribution Channel<br />
7. North America <strong>and</strong> Europe <strong>Artificial</strong> <strong>Pancreas</strong> Device System <strong>Market</strong> Analysis <strong>and</strong> Forecasts, By<br />
Region<br />
7.1. Basis Po<strong>in</strong>t Share (BPS) Analysis By Country<br />
7.2. Y-o-Y Growth Projections By Country<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
8
Table <strong>of</strong> Content<br />
7.3. <strong>Market</strong> Value Forecast By Region<br />
7.3.1. North America<br />
7.3.2. Western Europe<br />
7.3.3. Eastern Europe<br />
7.4. <strong>Market</strong> Attractiveness By Country/Region<br />
8. North America <strong>Artificial</strong> <strong>Pancreas</strong> Device System <strong>Market</strong> Analysis <strong>and</strong> Forecast<br />
8.1. Introduction<br />
8.1.1. Basis Po<strong>in</strong>t Share (BPS) Analysis By Country<br />
8.1.2. Y-o-Y Growth Projections By Country<br />
8.1.3. Key Regulations<br />
8.2. <strong>Market</strong> Value Forecast By Disease Indication, <strong>2016</strong>–<strong>2026</strong><br />
8.2.1. Diabetes Type 1<br />
8.2.2. Diabetes Type 2<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
9
To know more about us, please visit our website:<br />
www.futuremarket<strong>in</strong>sights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarket<strong>in</strong>sights.com<br />
For media queries, contact the press <strong>of</strong>fice at<br />
press@futuremarket<strong>in</strong>sights.com<br />
For other queries contact:<br />
Hari. T (Sr. Manager - Global Bus<strong>in</strong>ess Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarket<strong>in</strong>sights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consult<strong>in</strong>g Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
10
Change language